ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.
Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...
Jan 10, 2018 ... appellate case pending before the Ninth Circuit Court of Appeals. (Bekins v. AstraZeneca. Pharmaceuticals LP, et al., No.16-02732 (S.D. Cal.
Parties, docket activity and news coverage of federal case ATCHLEY et al v. ASTRAZENECA UK ... Defendant. ASTRAZENECA PHARMACEUTICALS LP ...
Jun 28, 2018 ... CINDI BEKINS V. ASTRAZENECA PHARMACEUTICALS LP, No. 17-55461 (9th Cir. 2018) case opinion from the US Court of Appeals for the ...
ALLERGAN, INC., ET AL, case number 2:08-cv-05135, from Pennsylvania Eastern ... UNITED STATES OF AMERICA v. ... ASTRAZENECA PHARMACEUTICALS LP ... MARGARET HALL, SNR DENTON US LLP TERMINATED: 07/03/2012.
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Summary of this case from United States ex rel. Wood v. Allergan, Inc. ... C. Michael Moore, L. Kym Davis Rogers, Margaret Hall, SNR Denton US LLP, Dallas, .... Defendants Allergan, Inc., Amgen, Inc., AstraZeneca Pharmaceuticals, L.P., Biogen .... On May 9, 2011, all of the states declined to intervene in this case , and the ...
Oct 12, 2016 ... Janssen Pharmaceuticals, Inc., et al., Case No. .... distributed by AstraZeneca Pharmaceuticals LP; and Jardiance and Glyxambi, marketed by.